To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
If you notice abnormally heavy bleeding, we recommend seeking immediate medical care to address potential complications associated with fibroid degeneration
This dual mechanism is why tirzepatide outperforms single-agonist GLP-1 medications in head-to-head comparisons
I know many mamas that had to stop their GLP-1 medications because they were too weak, felt too nauseous, and couldn't leave the house for fear of going to the bathroom